Suspected cancer: recognition and referral (NG12)Product type:GuidanceProgramme:NICE guidelineLast updated: 1 May 2025Published: 23 June 2015
Lung cancer: diagnosis and management (NG122)Product type:GuidanceProgramme:NICE guidelineLast updated: 8 March 2024Published: 28 March 2019
Suspected Cancer: recognition and referral (update)Status:In developmentProgramme:NICE guidelineExpected publication date: 13 March 2026
Durvalumab for adjuvant treatment of resectable non-small-cell lung cancer [ID1263]Status:In developmentProgramme:NICE guidelineExpected publication date: TBC